Search this website. You can use fund codes to locate specific funds

Tackling post-pandemic pharmaceutical challenges

A panel debate on the role of companies and investors

Last month we looked at post-pandemic pharmaceutical challenges as part of a panel session we hosted for the US Council of Institutional Investors (CII) virtual Spring 2021 conference.

Moderated by Katie Frame, our other engagers Dr Emma Berntman and Sarah Swartz were joined by Damiano de Felice, director of strategy at the Access to Medicine Foundation and Silas Holland, head of communications and external affairs at the AMR Action Fund.

The pandemic has highlighted the vulnerability of our healthcare systems and inequities in access to them. So we asked what can companies and investors do to mitigate these issues? What did we learn along the way in the race for the vaccine? And what has the pandemic shown in terms of links between the sustainability agenda and human health?

We take a global approach to engagement with companies so our panel applied an international lens to looking at these challenges, as well as wider issues such as antimicrobial resistance and equitable vaccine distribution. Inviting questions from the audience, make sure you catch up with this session to hear why companies and investors need to step up to tackle pharmaceutical challenges in a post-pandemic world.

Watch the recording in full below or click to jump to a section.

Opening remarks – 01:33

Stimulating greater investment into R&D – 26:58

Beyond Pharma – other actors tackling AMR – 33:32

Contributors of AMR – 42:06

Equitable vaccine distribution – 51:01

Closing remarks – 57:32

Related Insights

Public declaration of voting recommendations 2022
We record the public declarations that have been made so far in 2022. We plan to update this as and when we make further public declarations.
EOS Stewardship Report 2021
As EOS publishes its second UK Stewardship Report as a service provider we highlight some of the key takeaways and enhancements.
LyondellBasell case study
EOS engaged with LyondellBasell to set more ambitious climate targets.
Petrobras case study
We engaged with Petrobras in the development of its governance framework of subsidiaries.
Creating value by addressing social injustice
Social injustice occurs when people do not have access to the same rights and opportunities afforded to others, due to race, ethnicity, gender, sexuality, religion, disabilities or other characteristics.
The digital dilemma
The second article in our Q1 Public Engagement Report examines how we are engaging with social media and technology companies on digital rights.

EOS Client Service and Business Development

Amy D’Eugenio,
Head of Client Service and Business Development, EOS